Introduction
============

The new coronavirus (CoV) named by the World Health Organization (WHO) as "COVID-19" led to a pneumonia outbreak that recently started in Wuhan, Hubei Province China [@B1]. Its outbreak was linked to a large seafood and animal market and investigations are underway to determine the source of infection. Thousands of human infections and many export cases worldwide have been confirmed in China to date [@B2]. The main source of infection is pneumonia in patients infected with new coronavirus. Respiratory droplets are the main route of transmission and can also be transmitted through contact. People are often vulnerable. The main symptoms are respiratory symptoms such as fever and cough. However, recently, Professor An Ping et al. observed that the first symptom of some patients with pneumonia infected by the new coronavirus is only diarrhea, and it is suspected that the digestive system may also transmit the new coronavirus. At present, the mechanism by which digestive symptoms appear is unclear. The purpose of this study was to analyze the basic conditions of 70 patients with new-type coronavirus in Yongchuan Hospital, to analyze the blood test indicators of patients after infection, and the differences in the detection indexes of the infected people in Wuhan and Chongqing, and to analyze the clinical indicators of 8 patients with diarrhea. This will assist in the ability to find specific clinical testing indicators for patients with diarrhea.

Materials and Methods
=====================

Patients
--------

From January 26, 2019 to February 13, 2020, 70 patients diagnosed with 2019- nCoV according to the World Health Organization interim guidance for NCP and divided into diarrhea and non-diarrhea groups. All patients were confirmed to be positive for new coronavirus nucleic acid by real-time fluorescent RT-PCR. Infection samples were collected from Chongqing Hospital.

Blood sampling
--------------

Blood samples of the patients were collected by the nurse according to the doctor\'s order, and all patients were not treated before the blood sampling or did not receive the standardized treatment according to the diagnosis and treatment scheme of NCP.

Blood test
----------

Liver and kidney function, immunoglobulin complement, and fructosamine machines are all Hitachi 7600 automatic biochemical analyzers from Japan. The blood routine is a Japanese Sysmex XN-1000 automatic blood analyzer. The coagulation test is a Japanese Sysmex CA7000 automatic coagulation analyzer. Glycated hemoglobin is a Mindray H50 glycated hemoglobin analyzer. Erythrocyte sedimentation is an instrument that I haven\'t noticed, and I haven\'t changed it yet.

Statistical analysis
--------------------

All statistical analyses were performed using SPSS 20.0 (SPSS Inc., Chicago, IL, USA). Descriptive analyses were performed for categorical variables such as gender. Continuous variables such as inspection results were expressed as x ± s and compared using the independent samples t-test. P\<0.05 was considered as statistically significant.

Results
=======

Clinical characteristics of all patients
----------------------------------------

All patents\' clinical specimens for CONV-2019 diagnostic testing were obtained in accordance with the guidelines of the CDC [@B3],[@B4]. A description of the assay and sequence information for the RT-PCR primers and probes are available on the CDC Laboratory Information website for CONV-2019.

The study population included 70 hospitalized patients with confirmed CONV-2019. NCP patients (43males and 27 females) with a mean age of 48.57±17.80 (9\~82) years and only 4.3% of patients have lung-related diseases. Lesion site locations were prominent in both lungs (Table [1](#T1){ref-type="table"}).

Blood test indicators of all patients
-------------------------------------

All patients were tested for blood routine, liver and kidney function, coagulation, and immune status when they were admitted to the hospital. ESR(39/70), CRP (49/70), PCT (31/58), PT (41/67), IL6 (39/68), Cystatin C (23/68) were significantly elevated and the lymphocyte count (39/70), Prealbumin (39/67), GGT (54/70), CD4 (50/66), CD8 (24/70), T cell (26/65) were significantly decreased and the abnormal rate was more than 30%. At the same time, the positive rate of ESR, CRP, PT, IL6, lymphocyte count, GGT, Prealbumin and CD4 is more than 50%. These indicators may have more important clinical significance in the diagnosis process (Table [2](#T2){ref-type="table"}).

Comparison of diarrhea and non-diarrhea populations
---------------------------------------------------

However, the clinical examination of patients with diarrhea as the main symptom is not clear. We further analyzed the differences between 8 diarrhea patients and 62 non-diarrhea patients. The Eight patients had diarrhea as the first symptom, and the throat swab test was negative but the anal swab test was positive, and except for one patient who had slight inflammation of the lungs when admitted, the other patients had no obvious inflammatory changes in the lungs (Figure [1](#F1){ref-type="fig"}). There was no significant difference between the two groups in the general situation of age, gender, medical history, etc. (Table [3](#T3){ref-type="table"}). Comparison of clinical test indicators between the two groups of patients found that GGT (diarrhea *vs.* non-diarrhea: 20.75±14.12 *vs*. 54.74±59.61; P=0.000) was significantly different. The results indicate that GGT may be a deliberate detection index for patients with diarrhea. Further analysis of clinical test indicators of 8 patients showed that the Lymphocyte (4/8), PLT(2/8), CRP (4/8), PT (2/8), Prealbumin (5/8), Creatinine (2/8), Cystatin C (4/8), C4 (3/8) and CD8 (3/8) had significant differences (P\<0.05). Among these indicators, only Lymphocyte, CRP, Prealbumin and Cystatin C positive rate is more than 50%. Although there is no statistical difference in GGT, 100% of the 7 patients tested decreased, so it further illustrates the important detection value of GGT in patients with diarrhea.

Discussion
==========

So far, there is no vaccine or specific antiviral treatment for this emerging infectious disease, and effective control still depends mainly on early diagnosis, patient isolation and close contact monitoring [@B3]. Therefore, reliable and accurate diagnostic methods play a vital role in the field of disease control and prevention. However, some patients with diarrhea have a false-negative nucleic acid test. So, finding indicators that can predict gut symptoms in patients has important clinical significance. Our data found that the positive rate of ESR, CRP, PT, IL6, lymphocyte count, GGT, Prealbumin and CD4 was more than 50%. In addition, it was found that the Lymphocyte, PLT, CRP, PT, Prealbumin, Creatinine, Cystatin C, C4 and CD8 have clinical significance for patients in the diagnosis of diarrhea. GGT reduction is probably the most important indicator. Taken together, consistent with previous research [@B2],[@B5], the ESR, CRP, PT, IL6, lymphocyte count, GGT, Prealbumin and CD4 have important value in the diagnosis of COVID-19, and the decrease of GGT may be an important indicator for judging the intestinal dysfunction of patients.

Clinical Perspectives
=====================

Our study analyzed the detection of 70 patients with COVID-19 infection in Chongqing, and specifically analyzed the blood test of 8 patients with diarrhea as the first symptom. The decrease of GGT may be an important indicator for judging the intestinal dysfunction of patients. It has clinical significance for the diagnosis and treatment of diarrhea patients.

The study was supported by Chongqing Medical University New Coronary Virus Pneumonia Disease Progression and Prognosis Model Establishment Project (20200212-10).
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All data gathered and included in the present study are available and can be provided by the corresponding author upon reasonable request.
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###### 

Case characteristics group by 2019 ncov

  Variable                          Patient Number   Patient%
  --------------------------------- ---------------- ----------
  Age (mean±SD)                     48.57±17.80      
  **Age(y)**                                         
  \<60                              52               74.3
  ≥60                               18               25.7
  **Gender**                                         
  Male                              43               61.4
  Female                            27               38.6
  **Lung related basic diseases**                    
  no                                67               95.7
  yes                               3                4.3
  **Person category**                                
  A                                 29               41.4
  B                                 41               58.6
  **Location of lesion**                             
  Right                             10               14.3
  Left                              7                10.0
  Both                              46               65.7
  Normal                            7                10.0

A: Wuhan infected people; B: Infecting people in Chongqing.

###### 

Differences in clinical blood test indicators among all patients

  -------------------------------------------------------------------------------------------------------
  Variable              Normal NO. (mean±SD)   High NO. (mean±SD)   Low NO. (mean±SD)    P value (mean)
  --------------------- ---------------------- -------------------- -------------------- ----------------
  WBC                   59 (5.35±1.53)                              11 (2.90±0.53)       b, *P*=0.000

  Lymphocyte            31 (1.52±0.36)                              39 (0.76±0.23)       b, *P*=0.000

  Neutrophil cell       63 (3.5±1.09)          3 (7.55±3.61)        4 (1.23±0.28)        a, *P*=0.000\
                                                                                         b, *P*=0.000

  N% (40-75)            57 (64.81±8.56)        13 (81.68±6.20)                           a, *P*=0.000

  PLT                   55 (195.56±51.03)      3 (325±8.49)         12 (95.75±19.07)     a, *P*=0.000\
                                                                                         b, *P*=0.000

  HB                    54 (105.37±9.10)       8 (157.27±6.25)      8 (133.39±9.39)      a, *P*=0.000\
                                                                                         b, *P*=0.000

  CRP                   31 (3.11±2.82)         39 (36.26±27.79)                          a, *P*=0.000

  ESR                   21 (10.26±4.25)        49 (60.80±29.36)                          a, *P*=0.000

  PCT                   27 (0.06±0.03)         31 (0.12±0.17)                            a, *P*=0.041

  IL6                   29 (2.66±1.58)         39 (23.91±19.80)                          a, *P*=0.000

  BNT                   63 (76.13±83.57)       5 (500±320.20)                            a, *P*=0.041

  PT                    26 (12.07±0.66)        41 (14.69±1.39)                           a, *P*=0.000

  PTA                   62 (88.10±8.69)        6 (61.83±2.40)                            a, *P*=0.000

  d-dimer               59 (0.35±0.23)         3 (1.30±0.17)                             a, *P*=0.000

  ALT                   62 (24.03±9.23)        8 (89.75±37.72)                           a, *P*=0.002

  AST                   55 (25.07±5.90)        15 (56.73±29.20)                          a, *P*=0.001

  GGT                   9 (83.67±27.69)        7 (194.86±51.04)     54 (26.72±18.57)     a, *P*=0.001\
                                                                                         b, *P*=0.000

  Prealbumin            28 (242±28.17)                              39 (131.51±41.87)    b, *P*=0.000

  ALB                   58 (42.33±4.11)                             11 (33.38±1.42)      b, *P*=0.000

  CK                    51 (66.67±30.20)       11 (14.64±49.22)                          b, *P*=0.008

  CK-MB                 53 (0.46±0.45)         9 (5.97±2.05)                             a, *P*=0.043

  LDH                   57 (470.37±96.41)      7 (749.59±124.89)                         a, *P*=0.001

  Myoglobin             60 (31.05±14.61)       8 (313.45±584.95)                         a, *P*=0.214

  Creatinine            60 (67.62±13.23)       2 (128±8.49)         8 (38.75±3.85)       a, *P*=0.000\
                                                                                         b, *P*=0.000

  Urea nitrogen         60 (4.53±1.17)                              9 (2.52±0.29)        b, *P*=0.000

  α1 microglobulin      57 (21.84±4.57)        11 (34.69±4.44)                           a, *P*=0.000

  Cystatin C            45 (0.95±0.11)         23 (1.34±0.32)                            a, *P*=0.000

  Glycated hemoglobin   40 (5.74±0.63)         10 (8.14±2.80)                            a, *P*=0.027

  IgG                   52 (11.62±2.06)        10 (18.49±3.12)      2 (7.2±0.85)         a, *P*=0.000\
                                                                                         b, *P*=0.004

  IgA                   55 (1.95±0.53)         9 (4.53±1.27)                             a, *P*=0.000

  IgM                   61 (1.22±0.43)         2 (2.44±0.08)        1 (-)                a, *P*=0.000

  C3                    62 (1.32±0.17)         2 (1.75±0.05)                             a, *P*=0.001

  C4                    47 (0.31±0.06)         15 (0.48±0.10)       2 (0.16±0.01)        a, *P*=0.000\
                                                                                         b, *P*=0.001

  CD4                   16 (715.69±161.46)                          50 (314.78±126.11)   b, *P*=0.000

  CD8                   46 (365.47±175.03)                          24 (126.21±39.04)    b, *P*=0.000

  T cell                39 (917.44±333.36)                          26 (403.31±180.52)   b, *P*=0.000
  -------------------------------------------------------------------------------------------------------

Note: a: high vs normal, b: low vs normal.

###### 

Comparison of clinical data between diarrhea and non-diarrhea

  Variable                          Diarrhea (n=8)   Non-diarrhea (n=62)   P value
  --------------------------------- ---------------- --------------------- ---------
  Age (mean±SD)                     42.38±17.74      49.37±17.80           0.299
  **Age(y)**                                                               
  \<60                              8                43                    0.097
  ≥60                               0                19                    
  **Gender**                                                               
  Male                              5                39                    0.714
  Female                            3                23                    
  **Lung related basic diseases**                                          
  no                                8                59                    0.771
  yes                               0                3                     
  **Location of lesion**                                                   
  Right                             0                12                    0.420
  Left                              0                4                     
  Both                              1                38                    
  Normal                            7                8                     

###### 

Comparison of clinical indicators of diarrhea and non-diarrhea

  Variable              Diarrhea          No diarrhea       P value
  --------------------- ----------------- ----------------- -----------
  WBC                   4.50±1.18         5.21±2.08         0.353
  Lymphocyte            1.17±0.49         1.08±0.50         0.635
  Neutrophil cell       2.96±1.35         3.61±1.80         0.327
  N%                    63.25±15.19       67.84±10.30       0.266
  PLT                   182.63±46.88      180.81±66.96      0.941
  HB                    132.50±13.94      134.13±16.46      0.790
  CRP                   22.36±23.17       21.48±27.10       0.931
  ESR                   41.50±47.48       47.60±32.05       0.635
  PCT                   0.22±0.36         0.07±0.04         0.276
  IL6                   11.55±21.95       15.06±17.94       0.614
  BNT                   73.63±83.54       98.9±141.59       0.624
  PT                    12.93±1.60        13.74±1.84        0.241
  PTA                   87.65±7.21        83.67±16.34       0.502
  d-dimer               0.32±0.24         0.41±0.31         0.456
  ALT                   21.13±17.46       32.89±26.43       0.227
  AST                   27.00±16.54       32.48±19.63       0.453
  **GGT**               **20.75±14.12**   **54.74±59.61**   **0.000**
  Prealbumin            169.63±73.49      178.7±65.47       0.716
  ALB                   42.21±5.84        40.73±4.95        0.438
  CK                    67.63±40.13       117.04±150.14     0.361
  CK-MB                 0.34±0.20         0.81±1.44         0.364
  LDH                   521.38±189.60     532.76±169.68     0.861
  Myoglobin             27.49±8.54        69.18±223.90      0.603
  Creatinine            62.86±17.04       66.45±19.06       0.615
  Urea nitrogen         3.98±1.05         4.39±1.46         0.446
  α1 microglobulin      23.13±6.27        24.03±6.65        0.718
  Cystatin C            1.02±0.15         1.09±0.28         0.510
  Glycated hemoglobin   5.81±0.30         6.15±1.98         0.676
  IgG                   11.77±1.95        12.65±3.61        0.530
  IgA                   2.62±1.36         2.30±1.09         0.484
  IgM                   1.57±0.55         1.21±0.46         0.061
  C3                    1.29±0.12         1.34±0.19         0.506
  C4                    0.37±0.05         0.34±0.11         0.557
  CD4                   404.63±153.05     431.19±265.49     0.784
  CD8                   319.50±210.50     274.37±179.99     0.516
  T cell                764.13±349.30     733.25±438.44     0.849

###### 

Analysis of clinical detection indicators in patients with diarrhea

  Variable              Normal NO. (mean±SD)    High NO. (mean±SD)    Low NO. (mean±SD)       P value
  --------------------- ----------------------- --------------------- ----------------------- ------------------
  WBC                   7 (4.75±1.00)                                                         
  **Lymphocyte**        **4 (1.51±0.29)**                             **4 (0.83±0.39)**       **a, *P*=0.032**
  Neutrophil cell       6 (3.43±1.21)                                 2 (1.53±0.21)           a, *P*=0.081
  NEU                   7 (59.03±10.15)         1(92.8)                                       
  **PLT**               **6 (204.67±27.19)**                          **2 (116.50±4.95)**     **b, *P*=0.005**
  HB                    4 (135.57±11.77)                                                      
  **CRP**               **4 (2.60±2.73)**       **4 (42.13±14.29)**                           **a, *P*=0.010**
  ESR                   5 (12.2±6.22)           3 (90.33±45.72)                               a, *P*=0.096
  PCT                   4 (\<0.05)              4 (0.40±0.47)                                 a, *P*=0.235
  IL6                   6 (\<1.5)               3 (34.44±25.14)                               a, *P*=0.151
  BNT                   8 (73.63±83.54)                                                       
  **PT**                **6 (12.15±0.83)**      **2 (15.25±0.35)**                            **a, *P*=0.003**
  PTA                   8 (87.65±7.24)                                                        
  D-dimer               8 (0.32±0.24)                                                         
  ALT                   7 (15±2.31)                                                           
  AST                   7 (21.43±5.44)                                                        
  **GGT**                                                             **7(15.86±3.02)**       
  **Prealbumin**        **3 (248.33±28.10)**                          **5 (122.40±40.30)**    **a, *P*=0.003**
  ALB                   7 (43.26±5.44)                                                        
  CK                    7 (54.57±16.99)                                                       
  CK-MB                 8 (0.34±0.20)                                                         
  LDH                   6 (423.83±61.75)        2 (814±65.05)                                 
  Myoglobin             8 (27.49±8.54)                                                        
  **Creatinine**        **6 (71.00±9.23)**                            **2 (38.5±4.95)**       **b, *P*=0.004**
  Urea nitrogen         7 (4.27±0.71)                                                         
  α1 microglobulin      7 (21.53±4.69)                                                        
  **Cystatin C**        **4 (0.9±0,09)**        **4 (1.15±0.06)**                             **a, *P*=0.005**
  Glycated hemoglobin   6 (5.81±0.30)                                                         
  IgG                   6 (12.2±1.74)                                                         
  IgA                   5 (1.93±0.48)           2 (4.34±1.14)                                 a, *P*=0.237
  IgM                   6 (1.41±0.41)           1 (2.5)                                       
  C3                    7 (1.23±0.12)                                                         
  **C4**                **5 (0.34±0.03)**       **3 (0.43±0.01)**                             **a, *P*=0.017**
  **CD4**               **4 (509.05±9.00)**                           **4 (340.80±165.40)**   **b, *P*=0.084**
  **CD8**               **5 (429.20±189.63)**                         **3 (136.67±54.27)**    **b, *P*=0.044**
  T cell                7 (855.14±255.00)                             1 (127)                 

Note: a: high vs normal, b: low vs normal.

###### 

Test indicator description and normal value range

  Blood routine                                                             
  ------------------------------------------------------------------------- ----------------------------------------------------------------------------
  Leukocytes (×10^9^ per L, normal range 3.5-9.5)                           Lactate dehydrogenase (U/L, normal range 313-618)
  Neutrophils (×10^9^ per L, normal range 1.8-6.3)                          Myoglobin (ng/mL, normal range Male 0-121; Female 0-61.5)
  Neutrophil percentage (Neutrophil percentage 40-75)                       Serum Creatinine (umol/L, normal range Male 53-123; Female 62-106)
  Lymphocytes (×10^9^ per L, normal range 1.1-3.2)                          Blood Urea nitrogen (mmol/L, normal range 2.86-8.20)
  Platelets (×10^9^ per L, normal range 125-350)                            α1 microglobulin (mg/L, normal range 10-30)
  Hemoglobin (g/L, normal range Male 130-175; Female 115-150)               Cystatin C (mg/L, normal range 0.51-1.09)
  Brain natriuretic peptide (pg/ml, normal range 1-125)                     Glycated hemoglobin (%, normal range 4.5-6.3)
  Coagulation function                                                      Immunoglobulin complement G (G/L, normal range 8-16)
  Prothrombin time (s, normal range 11-14.5)                                Immunoglobulin complement A (G/L, normal range 0.7-3.3)
  D-dimer (ug/L, normal range 0.00-0.5)                                     Immunoglobulin complement M (G/L, normal range 0.5-2.2)
  Prothrombin time activity (%, normal range 70-120)                        Complement 3 (G/L, normal range 0.8-1.6)
  Blood biochemistry                                                        Complement 4 (G/L, normal range 0.2-0.4)
  Alanine aminotransferase (U/L, normal range Male 9-50; Female 7-40)       Infection-related factors
  Aspartate aminotransferase (U/L, normal range Male 15-40; Female 13-35)   Erythrocyte sedimentation rate (mm/h, normal range Male 0-15; Female 0-20)
  Gamma glutaminase (GGT) (U/L, normal range Male 10-60; Female 7-45)       C-reactive protein (mg/L, normal range 0-10)
  Prealbumin (mg/L, normal range 200-400)                                   Procalcitonin (ng/ml, normal range 0-0.05)
  Albumin (G/L, normal range 35-55)                                         Interleukin -6 (Pg/ml, normal range 0-7)
  Creatine kinase (U/L, normal range Male 55-170; Female **30-135**)        CD4 T-cell (per ul, normal range 493-1191)
  Creatine kinase isoenzyme (ng/ml, normal range 0.0-3.4)                   CD8 T-cell (per ul, normal range 182-785)
                                                                            Total T-Cell (per ul, normal range 644-2201)
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